Response Genetics' Q3 Revenues Climb on ResponseDx Uptick | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics reported after the close of the market Monday that its third-quarter revenues increased 15 percent as sales of its ResponseDx tests rose sharply quarter to quarter.

The Los Angeles-based molecular diagnostics firm brought in total revenues of $2.3 million for the three-month period ended Sept. 30, compared to $2 million for the third quarter of 2008. It said that revenues from its ResponseDx: Lung and ResponseDx: Colon tests, which were launched in the third quarter of 2008, more than doubled compared to the second quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.